| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.12▼ | 4.12▼ | 4.11▼ | 4.32▼ | 4.55▼ |
| MA10 | 4.15▼ | 4.15▼ | 4.18▼ | 4.39▼ | 4.88▼ |
| MA20 | 4.20▼ | 4.21▼ | 4.24▼ | 4.59▼ | 5.20▼ |
| MA50 | 4.27▼ | 4.39▼ | 4.58▼ | 5.01▼ | 4.14▼ |
| MA100 | 4.53▼ | 4.80▼ | 4.93▼ | 5.24▼ | 4.53▼ |
| MA200 | 4.91▼ | 5.06▼ | 5.20▼ | 4.28▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | 0.001▲ | 0.004▲ | -0.021▼ | -0.199▼ |
| RSI | 43.356▼ | 42.844▼ | 39.704▼ | 33.293▼ | 43.726▼ |
| STOCH | 11.942▼ | 11.613▼ | 18.880▼ | 25.228 | 26.373 |
| WILL %R | -97.619▼ | -88.333▼ | -88.710▼ | -93.486▼ | -97.073▼ |
| CCI | -91.620 | -79.663 | -95.181 | -179.824▼ | -178.752▼ |
|
Wednesday, December 03, 2025 05:54 AM
Simultaneously, BGLC has obtained exclusive, perpetual rights to manufacture, market, and distribute VitaGuard™ across all ASEAN markets, solidifying the Company as the sole provider of this advanced ...
|
|
Wednesday, December 03, 2025 05:54 AM
Simultaneously, BGLC has obtained exclusive, perpetual rights to manufacture, market, and distribute VitaGuard™ across all ASEAN markets, solidifying the Company as the sole provider of this advanced ...
|
|
Wednesday, December 03, 2025 05:50 AM
BioNexus Gene Lab (BGLC) announced the completion of its strategic transaction with Fidelion Diagnostics and Tongshu Biotechnology. With the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/12/25 | 4.08 | 4.18 | 4.05 | 4.11 | 42,254 |
| 04/12/25 | 4.16 | 4.37 | 4.0505 | 4.33 | 94,131 |
| 03/12/25 | 4.39 | 4.5983 | 4.20 | 4.40 | 727,133 |
| 02/12/25 | 4.40 | 4.54 | 4.11 | 4.35 | 2,936,390 |
| 01/12/25 | 4.50 | 4.5479 | 4.40 | 4.43 | 5,981 |
| 28/11/25 | 4.50 | 4.54 | 4.50 | 4.54 | 3,221 |
| 26/11/25 | 4.34 | 4.9711 | 4.32 | 4.54 | 27,611 |
| 25/11/25 | 4.4197 | 4.43 | 4.31 | 4.32 | 10,386 |
| 24/11/25 | 4.50 | 4.51 | 4.35 | 4.41 | 6,844 |
| 21/11/25 | 4.41 | 4.515 | 4.41 | 4.455 | 3,798 |
|
|
||||
|
|
||||
|
|